San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, RDMD Inc. is raising $9,499,992.00 in new funding. Sources indicate as part of senior management President, Nancy Yu played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About RDMD Inc.

RDMD’s mission is to empower patients and communities to accelerate the development of treatments for rare diseases of all kinds. We are a medical data science company that helps to identify patients and generate regulatory-grade evidence to enable drug approvals and real world evidence in rare disease. RDMD is privately funded by Lux Capital and Village Global, a venture capital firm with a network of LPs including Reid Hoffman, Bill Gates, Mark Zuckerberg, and Jeff Bezos.

To learn more about RDMD Inc., visit http://www.rdmd.com/

Contact:
Nancy Yu, President
408-596-1386
https://www.linkedin.com/in/yunancy/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved